AMPE - Ampio Pharmaceuticals, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
-
0
-
-
1,162
Cost of Revenue
333
523
568
950
2,044
Gross Profit
-
-
-
-
-882
Operating Expenses
Research Development
8,614
6,829
10,421
10,546
18,961
Selling General and Administrative
5,020
3,832
4,576
5,586
13,460
Total Operating Expenses
13,634
10,661
14,997
16,132
32,421
Operating Income or Loss
-13,967
-11,184
-15,565
-17,082
-33,302
Interest Expense
-
5
-
-
-
Total Other Income/Expenses Net
2,831
45,175
-36,330
-2,105
-78
Income Before Tax
-11,084
33,987
-51,892
-19,164
-33,714
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-11,084
33,987
-51,892
-19,164
-33,714
Net Income
-11,085
33,986
-51,892
-19,164
-32,010
Net Income available to common shareholders
-11,085
33,986
-51,892
-19,164
-32,010
Reported EPS
Basic
-
0.46
-0.79
-0.36
-0.62
Diluted
-
0.46
-0.79
-0.36
-0.62
Weighted average shares outstanding
Basic
-
73,358
65,297
53,773
51,992
Diluted
-
73,358
65,297
53,773
51,992
EBITDA
-
-9,902
-14,350
-15,868
-32,166